scholarly article | Q13442814 |
P356 | DOI | 10.1097/MED.0B013E32834C800D |
P698 | PubMed publication ID | 21986512 |
P2093 | author name string | Michael Freemark | |
Dorothee Newbern | |||
P433 | issue | 6 | |
P304 | page(s) | 409-416 | |
P577 | publication date | 2011-12-01 | |
P1433 | published in | Current Opinion in Endocrinology, Diabetes and Obesity | Q15756285 |
P1476 | title | Placental hormones and the control of maternal metabolism and fetal growth | |
P478 | volume | 18 |
Q28087609 | 60 YEARS OF NEUROENDOCRINOLOGY: The hypothalamo-prolactin axis |
Q37082073 | A Prolactin Family Paralog Regulates Placental Adaptations to a Physiological Stressor |
Q26770235 | A Role for the Placenta in Programming Maternal Mood and Childhood Behavioural Disorders |
Q55379535 | Adipokine-myokine-hepatokine compartment-system in mothers and children: An explorative study. |
Q37979744 | Adipokines, an adipose tissue and placental product with biological functions during pregnancy |
Q42339103 | An increase in immature β-cells lacking Glut2 precedes the expansion of β-cell mass in the pregnant mouse. |
Q42670065 | Antibiotic use during pregnancy: how bad is it? |
Q48717665 | Biochemical markers of placental dysfunction in assisted conception |
Q36785031 | Body fat mass and the proportion of very large adipocytes in pregnant women are associated with gestational insulin resistance |
Q35971314 | Chronic Protein Restriction in Mice Impacts Placental Function and Maternal Body Weight before Fetal Growth |
Q38267786 | Clinical Recommendations for the Use of Islet Cell Autoantibodies to Distinguish Autoimmune and Non-Autoimmune Gestational Diabetes |
Q41114661 | Connections between the human gut microbiome and gestational diabetes mellitus. |
Q37341979 | Defective prolactin signaling impairs pancreatic β-cell development during the perinatal period |
Q37286645 | Developmental programming of growth: genetic variant in GH2 gene encoding placental growth hormone contributes to adult height determination |
Q35174892 | Developmental programming: the role of growth hormone |
Q92293485 | Diabetes in pregnancy and epigenetic mechanisms-how the first 9 months from conception might affect the child's epigenome and later risk of disease |
Q47557775 | Dietary patterns and their association with adiponectin and leptin concentrations throughout pregnancy: a prospective cohort. |
Q52783467 | Differences in affinities between the homologous and the heterologous rabbit prolactin-receptor interaction with respect to proliferation and differentiation activities. |
Q35886470 | Differential placental expression profile of human Growth Hormone/Chorionic Somatomammotropin genes in pregnancies with pre-eclampsia and gestational diabetes mellitus |
Q90400934 | Dramatic Remodeling of the Gut Microbiome Around Parturition and Its Relationship With Host Serum Metabolic Changes in Sows |
Q35124584 | Early life events influence whole-of-life metabolic health via gut microflora and gut permeability |
Q48162241 | Early versus 6-12 week postpartum glucose tolerance testing for women with gestational diabetes |
Q96127845 | Ecological succession in the vaginal microbiota during pregnancy and birth |
Q53798493 | Effect of pregnancy on insulin requirements differs between type 1 and type 2 diabetes: A cohort study of 222 pregnancies. |
Q36280137 | Effects of dietary nutrient levels on microbial community composition and diversity in the ileal contents of pregnant Huanjiang mini-pigs |
Q36575544 | Elevated placental adenosine signaling contributes to the pathogenesis of preeclampsia |
Q92188455 | Exploring Fetal Sex Dimorphism in the Risk Factors of Gestational Diabetes Mellitus-A Prospective Cohort Study |
Q57081259 | Extracellular vesicles generated by placental tissues ex vivo: A transport system for immune mediators and growth factors |
Q37070253 | Factors determining insulin requirements in women with type 1 diabetes mellitus during pregnancy: a review |
Q89819172 | Fecal bacteria and metabolite responses to dietary lysozyme in a sow model from late gestation until lactation |
Q64062127 | Fetal growth in environmental epidemiology: mechanisms, limitations, and a review of associations with biomarkers of non-persistent chemical exposures during pregnancy |
Q38266407 | Fetal outcome after prenatal exposure to chemotherapy and mechanisms of teratogenicity compared to alcohol and smoking |
Q36796088 | Fetal pancreas transplants are dependent on prolactin for their development and prevent type 1 diabetes in syngeneic but not allogeneic mice. |
Q35694956 | Formaldehyde Crosses the Human Placenta and Affects Human Trophoblast Differentiation and Hormonal Functions. |
Q47260586 | GRP94 is an Essential Regulator of Pancreatic β Cell Development, Mass and Function in Male Mice |
Q38300139 | Gene Expression in Placentas From Nondiabetic Women Giving Birth to Large for Gestational Age Infants. |
Q38709349 | Genetics of Gestational Diabetes Mellitus and Maternal Metabolism |
Q35837851 | Genetics of recurrent miscarriage: challenges, current knowledge, future directions |
Q37589850 | Genetics, genomics and metabolomics: new insights into maternal metabolism during pregnancy |
Q55511996 | High Fructose Intake During Pregnancy in Rats Influences the Maternal Microbiome and Gut Development in the Offspring. |
Q36421887 | Host remodeling of the gut microbiome and metabolic changes during pregnancy |
Q47995999 | Human placental growth hormone is increased in maternal serum at 20 weeks of gestation in pregnancies with large-for-gestational-age babies. |
Q58760266 | Impacts of bisphenol A (BPA) and phthalate exposures on epigenetic outcomes in the human placenta |
Q92426139 | Increased maternal serum placental growth hormone variant in pregnancies complicated by otosclerosis |
Q89810520 | Inhibition of IL-1beta improves Glycaemia in a Mouse Model for Gestational Diabetes |
Q31086034 | Is Mid-trimester Insulin Resistance Predictive of Subsequent Puerperal Infection? A Secondary Analysis of Randomized Trial Data |
Q92528354 | Ketonuria Is Associated with Changes to the Abundance of Roseburia in the Gut Microbiota of Overweight and Obese Women at 16 Weeks Gestation: A Cross-Sectional Observational Study |
Q37699546 | Knockdown of prolactin receptors in a pancreatic beta cell line: effects on DNA synthesis, apoptosis, and gene expression |
Q35091429 | Maternal factors associated with fetal growth and birthweight are independent determinants of placental weight and exhibit differential effects by fetal sex. |
Q37367108 | Maternal prenatal depression is associated with decreased placental expression of the imprinted gene PEG3 |
Q39180508 | Metabolic Adaptations in Pregnancy: A Review |
Q92324109 | Metformin therapy before conception versus throughout the pregnancy and risk of gestational diabetes mellitus in women with polycystic ovary syndrome: a systemic review, meta-analysis and meta-regression |
Q26740662 | Microbial Changes during Pregnancy, Birth, and Infancy |
Q47132983 | Microbial Mechanistic Insight into the Role of Inulin in Improving Maternal Health in a Pregnant Sow Model |
Q28083570 | Microbial endocrinology: the interplay between the microbiota and the endocrine system |
Q33716566 | Microbial succession in the gut: directional trends of taxonomic and functional change in a birth cohort of Spanish infants. |
Q39146308 | Microbiome, autoimmunity, allergy, and helminth infection: The importance of the pregnancy period |
Q34996173 | Milk consumption during pregnancy increases birth weight, a risk factor for the development of diseases of civilization |
Q37033035 | Mitochondrial function and glucose metabolism in the placenta with gestational diabetes mellitus: role of miR-143. |
Q55254265 | Multilevel social structure and diet shape the gut microbiota of the gelada monkey, the only grazing primate. |
Q36926481 | New insights into gestational glucose metabolism: lessons learned from 21st century approaches |
Q93369636 | Novel roles of mechanistic target of rapamycin signaling in regulating fetal growth† |
Q90701664 | Offspring genetic effects on maternal care |
Q64104679 | Offspring of Mice Exposed to a Low-Protein Diet in Utero Demonstrate Changes in mTOR Signaling in Pancreatic Islets of Langerhans, Associated with Altered Glucagon and Insulin Expression and a Lower β-Cell Mass |
Q41440755 | Oxidative Stress in Pancreatic Beta Cell Regeneration. |
Q37236831 | Parity and type 2 diabetes mellitus: a study of insulin resistance and β-cell function in women with multiple pregnancies. |
Q38680047 | Periconception endogenous and exogenous maternal sex steroid hormones and risk of asthma and allergy in offspring: protocol for a systematic review and meta-analysis. |
Q46307098 | Perinatal outcome in pregnant women with cancer: are there any effects of chemotherapy? |
Q99410752 | Perturbations of gut microbiota in gestational diabetes mellitus patients induce hyperglycemia in germ-free mice |
Q26746794 | Physiological changes in pregnancy |
Q47153631 | Placental Nutrient Transport in Gestational Diabetic Pregnancies |
Q30245567 | Placental Origins of Chronic Disease |
Q36654244 | Placental PHLDA2 expression is increased in cases of fetal growth restriction following reduced fetal movements |
Q28830956 | Placental endoplasmic reticulum stress in gestational diabetes: the potential for therapeutic intervention with chemical chaperones and antioxidants |
Q41126075 | Placental melatonin system is present throughout pregnancy and regulates villous trophoblast differentiation |
Q26766128 | Placental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human Development |
Q90379803 | Plasma Prolactin and Progesterone Levels and the Risk of Gestational Diabetes: A Prospective and Longitudinal Study in a Multiracial Cohort |
Q36211905 | Possibility to predict early postpartum glucose abnormality following gestational diabetes mellitus based on the results of routine mid-gestational screening. |
Q87054690 | Predicting gestational diabetes mellitus during the first trimester using anthropometric measurements and HOMA-IR |
Q36455272 | Pregnancy Hyperglycemia in Prolactin Receptor Mutant, but Not Prolactin Mutant, Mice and Feeding-Responsive Regulation of Placental Lactogen Genes Implies Placental Control of Maternal Glucose Homeostasis |
Q39446485 | Pregnancy and acromegaly. |
Q96230008 | Pregnancy and cardiovascular disease |
Q41647584 | Pregnancy in acromegaly patients treated with pegvisomant |
Q27014191 | Prescribing physical activity to prevent and manage gestational diabetes |
Q38282713 | Prolactin (PRL) in adipose tissue: regulation and functions. |
Q46558227 | Prolactin promotes normal liver growth, survival, and regeneration in rodents: effects on hepatic IL-6, suppressor of cytokine signaling-3, and angiogenesis. |
Q58575891 | Relationship maternal subcutaneous adipose tissue thickness and development of gestational diabetes mellitus |
Q56973886 | Reproductive endocrinology: Maternal and fetal insulin levels at birth in women with PCOS |
Q96609649 | Reproductive hormones mediate changes in the gut microbiome during pregnancy and lactation in Phayre's leaf monkeys |
Q33759053 | Rising maternal circulating GH during murine pregnancy suggests placental regulation |
Q35113479 | SOCS3 deficiency in leptin receptor-expressing cells mitigates the development of pregnancy-induced metabolic changes. |
Q35731477 | Secretor Status Is Strongly Associated with Microbial Alterations Observed during Pregnancy |
Q33682164 | Serotonin transporter deficiency drives estrogen-dependent obesity and glucose intolerance |
Q33711860 | Serum from pregnant women with gestational diabetes mellitus increases the expression of FABP4 mRNA in primary subcutaneous human pre-adipocytes |
Q36072544 | Sexual Dimorphism in Adverse Pregnancy Outcomes - A Retrospective Australian Population Study 1981-2011. |
Q93008075 | Stages of pregnancy and weaning influence the gut microbiota diversity and function in sows |
Q36890621 | Targeted deletion of growth hormone (GH) receptor in macrophage reveals novel osteopontin-mediated effects of GH on glucose homeostasis and insulin sensitivity in diet-induced obesity |
Q55515339 | The Emerging Role of Biomarkers in the Diagnosis of Gestational Diabetes Mellitus. |
Q92448179 | The Evolving Microbiome from Pregnancy to Early Infancy: A Comprehensive Review |
Q92553206 | The association between dietary patterns before and in early pregnancy and the risk of gestational diabetes mellitus (GDM): Data from the Malaysian SECOST cohort |
Q90115661 | The matter of the reproductive microbiome |
Q92189764 | The parental brain and behavior: A target for endocrine disruption |
Q27687553 | The placenta: a multifaceted, transient organ |
Q38524488 | The prolactin receptor as a therapeutic target in human diseases: browsing new potential indications |
Q47441324 | The relationship between moderate-to-vigorous intensity physical activity and insulin resistance, insulin-like growth factor (IGF-1)-system 1, leptin and weight change in healthy women during pregnancy and after delivery |
Q50058520 | The role of gut microbiota in the effects of maternal obesity during pregnancy on offspring metabolism |
Q27008068 | The role of placental nutrient sensing in maternal-fetal resource allocation |
Q89829035 | Time course of metabolic status in pregnant women: The Japan Environment and Children's Study |
Q58798673 | Triglycerides/Glucose and Triglyceride/High-Density Lipoprotein Cholesterol Indices in Normal and Preeclamptic Pregnancies: A Longitudinal Study |
Q38890161 | Trimester-Specific Urinary Bisphenol A Concentrations and Blood Glucose Levels Among Pregnant Women From a Fertility Clinic |
Q89918519 | UCN2: a new candidate influencing pancreatic β-cell adaptations in pregnancy |
Search more.